Is Lipella Pharmaceuticals Inc. (LIPO) a Buy, Sell, or Hold?
OTC : LIPO
Lipella Pharmaceuticals Inc.
$0.035 USD
-$0.03 (-45.82%)
- Volume
- 145.22K
- Average Volume
- 36.56K
- Market Capitalization
- $161.73K
- P/E Ratio
- -0.03
- Dividend Yield
- 0.00%
- Price Target
- $2.00
- Year High
- $0.80
- Year Low
- $0.02
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.24
Insider Activity Summary (Last 12 Months)
Insiders Buying
21
Insiders Selling
2
Amount of Insider Selling
$314.84K
LIPO Insider Buying/Selling by Quarter
LIPO Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Kaufman Jonathan H | director, 10 percent owner, officer: See remarks below. | 2025-04-03 | J-Other | 1 | 2025-04-07 |
| Kaufman Jonathan H | director, 10 percent owner, officer: See remarks below. | 2025-04-03 | J-Other | 1 | 2025-04-07 |
| Kaufman Jonathan H | director, 10 percent owner, officer: See remarks below. | 2025-03-13 | J-Other | 1 | 2025-03-17 |
| Kaufman Jonathan H | director, 10 percent owner, officer: See remarks below. | 2025-03-13 | J-Other | 1 | 2025-03-17 |
| Kaufman Jonathan H | director, 10 percent owner, officer: See remarks below. | 2025-03-10 | J-Other | 1 | 2025-03-11 |
| Kaufman Jonathan H | director, 10 percent owner, officer: See remarks below. | 2025-03-10 | J-Other | 1 | 2025-03-11 |
| Kaufman Jonathan H | director, 10 percent owner, officer: See remarks below. | 2025-02-28 | J-Other | 1 | 2025-03-03 |
| Kaufman Jonathan H | director, 10 percent owner, officer: See remarks below. | 2025-02-28 | J-Other | 1 | 2025-03-03 |
| Kaufman Jonathan H | director, 10 percent owner, officer: See remarks below. | 2025-01-15 | J-Other | 1 | 2025-01-17 |
| Kaufman Jonathan H | director, 10 percent owner, officer: See remarks below. | 2025-01-15 | J-Other | 1 | 2025-01-17 |
| Kaufman Jonathan H | director, 10 percent owner, officer: See remarks below. | 2024-12-31 | J-Other | 1 | 2025-01-03 |
| Kaufman Jonathan H | director, 10 percent owner, officer: See remarks below. | 2024-12-31 | J-Other | 1 | 2025-01-03 |
| Kaufman Jonathan H | director, 10 percent owner, officer: See remarks below. | 2024-12-23 | J-Other | 1 | 2024-12-27 |
| Kaufman Jonathan H | director, 10 percent owner, officer: See remarks below. | 2024-12-23 | J-Other | 1 | 2024-12-27 |
| Kaufman Jonathan H | director, 10 percent owner, officer: See remarks below. | 2024-05-14 | P-Purchase | 0.759 | 2024-05-15 |
| Pruchnic Ryan | director | 2024-03-15 | A-Award | 0.77 | 2024-03-19 |
| Yoshimura Naoki | director | 2024-03-15 | A-Award | 0.77 | 2024-03-19 |
| Chancellor Michael B | director, 10 percent owner, officer: Chief Medical Officer | 2024-03-15 | A-Award | 0.77 | 2024-03-19 |
| Birder Lori | director | 2024-03-15 | A-Award | 0.77 | 2024-03-19 |
| Kaufman Jonathan H | director, 10 percent owner, officer: See remarks below. | 2024-03-19 | P-Purchase | 0.8721 | 2024-03-19 |
| Kaufman Jonathan H | director, 10 percent owner, officer: See remarks below. | 2024-03-18 | P-Purchase | 0.7883 | 2024-03-19 |
| Kaufman Jonathan H | director, 10 percent owner, officer: See remarks below. | 2024-03-15 | A-Award | 0.77 | 2024-03-19 |
| Johnston Douglas | officer: Chief Financial Officer | 2024-03-15 | A-Award | 0.77 | 2024-03-19 |
| Cohen Daniel R | director | 2024-03-15 | A-Award | 0.77 | 2024-03-19 |
| Kim Byong | director | 2024-03-15 | A-Award | 0.77 | 2024-03-19 |
| Kaufman Jonathan H | director, 10 percent owner, officer: See remarks below. | 2024-03-13 | A-Award | 0.6901 | 2024-03-15 |
| Chancellor Michael B | director, 10 percent owner, officer: Chief Medical Officer | 2024-03-13 | A-Award | 0.6901 | 2024-03-15 |
| Cohen Daniel R | director | 2023-06-16 | A-Award | 2.19 | 2023-06-21 |
| Battleman David S. | director | 2023-06-16 | A-Award | 2.19 | 2023-06-21 |
| Pruchnic Ryan | director | 2023-06-16 | A-Award | 2.19 | 2023-06-21 |
| Kaufman Jonathan H | director, 10 percent owner, officer: See remarks below. | 2023-06-16 | A-Award | 2.19 | 2023-06-21 |
| Chancellor Michael B | director, 10 percent owner, officer: Chief Medical Officer | 2023-06-16 | A-Award | 2.19 | 2023-06-21 |
| Yoshimura Naoki | director | 2023-06-16 | A-Award | 2.19 | 2023-06-21 |
| Kim Byong | director | 2023-06-16 | A-Award | 2.19 | 2023-06-21 |
| Johnston Douglas | officer: Chief Financial Officer | 2023-06-16 | A-Award | 2.19 | 2023-06-21 |
| Birder Lori | director: | 2023-06-17 | 0 | 2023-06-21 | |
| Cohen Daniel R | director: | 2023-03-21 | 0 | 2023-03-30 | |
| Yoshimura Naoki | director | 2021-09-03 | 5 | 2023-01-03 | |
| Battleman David S. | director | 2021-09-03 | 5 | 2023-01-03 | |
| Chancellor Michael B | officer: Chief Medical Officer | 2022-12-22 | J-Other | 5.75 | 2022-12-27 |
| Chancellor Michael B | officer: Chief Medical Officer | 2022-12-19 | 5 | 2022-12-20 | |
| Chancellor Michael B | officer: Chief Medical Officer | 2022-12-19 | 0 | 2022-12-20 | |
| Kaufman Jonathan H | officer: See Remarks | 2022-12-19 | 5 | 2022-12-20 | |
| Kaufman Jonathan H | officer: See Remarks | 2022-12-19 | 0 | 2022-12-20 | |
| Kim Byong | director | 2022-02-22 | 5 | 2022-12-20 | |
| Johnston Douglas | officer | 2022-12-19 | 0 | 2022-12-20 | |
| Johnston Douglas | None | 2022-12-19 | None | 2022-12-20 | |
| Pruchnic Ryan | director | 2021-09-03 | 5 | 2022-12-20 |